These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 3309806)

  • 1. [Pharmacokinetics of habekacin in patients with chronic renal insufficiency].
    Fillastre JP; Leroy A; Humbert G; Moulin B; Bernadet P; Josse S
    Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):739-41. PubMed ID: 3309806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of habekacin in patients with renal insufficiency.
    Fillastre JP; Leroy A; Humbert G; Moulin B; Bernadet P; Josse S
    Antimicrob Agents Chemother; 1987 Apr; 31(4):575-7. PubMed ID: 3606062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacokinetics of arbekacin in dogs. I. Serum concentration and urinary excretion].
    Tomono N; Sannomiya F; Nakayoshi T; Shinkai S; Fujita M
    Jpn J Antibiot; 1987 Feb; 40(2):365-75. PubMed ID: 3599385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacokinetics of dibekacin in patients with chronic renal impairment].
    Viotte G; Leroy A; Godin M; Fillastre JP
    Nouv Presse Med; 1982 Nov; 11(46):3414-8. PubMed ID: 7155849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacokinetics of arbekacin in healthy volunteers and patients with renal insufficiency].
    Kumon H; Mizuno A; Nasu Y; Tsugawa M; Kishi M; Ohmori H
    Jpn J Antibiot; 1989 Jan; 42(1):200-7. PubMed ID: 2709618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical study of aminoglycosides on renal dysfunction--pharmacokinetics of arbekacin and its elimination effects by hemodialysis and adsorption with charcoal].
    Arakawa S; Maeda H; Fujii A; Kamidono S; Hamada K; Miyazaki S; Hara S
    Hinyokika Kiyo; 1989 Apr; 35(4):697-704. PubMed ID: 2735273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Habekacin: a new aminoglycoside. Study of nephrotoxicity in rats in comparison with gentamicin, netilmicin and amikacin].
    Olier B; Morin JP; Thomas N; Fillastre JP
    Pathol Biol (Paris); 1988 Jun; 36(6):795-800. PubMed ID: 3047639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of dibekacin in normal subjects and in patients with renal failure.
    Leroy A; Humbert G; Fillastre JP
    J Antimicrob Chemother; 1980 Jan; 6(1):113-20. PubMed ID: 7358604
    [No Abstract]   [Full Text] [Related]  

  • 9. [Absorption, distribution, and excretion of arbekacin after intravenous and intramuscular administration in rats].
    Mitomi N; Matsumoto T; Fujigaki M; Komiya I; Kai F
    Jpn J Antibiot; 1987 Feb; 40(2):357-64. PubMed ID: 3599384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic studies with dibekacin, a new aminoglycoside, after intravenous and intramuscular administration to human volunteers.
    Goto M; Sugiyama M; Ishizaki T
    Antimicrob Agents Chemother; 1980 Sep; 18(3):372-6. PubMed ID: 6775594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacokinetics of dibekacin in subjects with normal renal function].
    Thauvin C; Borsa F; Leroy A; Humbert G
    Nouv Presse Med; 1982 Nov; 11(46):3410-3. PubMed ID: 7155848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of cefadroxil in normal subjects and in patients with renal insufficiency.
    Humbert G; Leroy A; Fillastre JP; Godin M
    Chemotherapy; 1979; 25(4):189-95. PubMed ID: 456077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disposition kinetics of dibekacin in normal subjects and in patients with renal failure.
    Arancibia A; Chávez J; Ibarra R; Ruiz I; Icarte A; Thambo S; Chávez H
    Int J Clin Pharmacol Ther Toxicol; 1987 Jan; 25(1):38-43. PubMed ID: 3557728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacokinetic studies on intravenous drip infusion of dibekacin in elderly subjects without apparent renal failure (author's transl)].
    Sawae Y; Okada K; Umemura K
    Jpn J Antibiot; 1982 Mar; 35(3):770-8. PubMed ID: 7097979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study on administration method of dibekacin].
    Soejima R; Tano Y; Niki Y; Katoh O
    Jpn J Antibiot; 1982 Dec; 35(12):2768-72. PubMed ID: 7182532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aminoglycosides in intermittent hemodialysis: pharmacokinetics with individual dosing.
    Dager WE; King JH
    Ann Pharmacother; 2006 Jan; 40(1):9-14. PubMed ID: 16332944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacokinetics of arbekacin in dogs. II. The distribution of arbekacin in tissues].
    Tomono N; Nakayoshi T; Shinkai S; Fujita M
    Jpn J Antibiot; 1987 Feb; 40(2):377-84. PubMed ID: 3599386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative vestibular toxicity of dibekacin, habekacin and cisplatin.
    Caston J; Doinel L
    Acta Otolaryngol; 1987; 104(3-4):315-21. PubMed ID: 3499743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Habekacin: nephrotoxicity, pharmacokinetics and prophylactic efficacy in rats.
    Stewens J; Marre R; Engelbart K; Schulz E; Sack K
    Arzneimittelforschung; 1985; 35(9):1440-6. PubMed ID: 3910052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disposition of Dibekacin in patients undergoing haemodialysis.
    Campillo JA; Lanao JM; Dominguez-Gil A; Rubio F; Martin A
    Eur J Clin Pharmacol; 1980 Oct; 18(4):347-50. PubMed ID: 7439256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.